Grand Pharmaceutical (China) Co., Ltd.

Originally from a pharmaceutical plant located in the Revolutionary Base Area_Taihang Mountains, GrandPharma (China) Co., Ltd. is a modern pharmaceutical group with a glorious history of *0 years. During Anti-Japanese War and War of Liberation, we have made great contributions to the whole country. In ***2, we joined China Grand Enterprises. And in ***8, we have become the major assets of Grand Pharmaceutical and Health Holdings Limited, which is listed in Hong Kong Stock Market (HK****2).

Grand Pharma, which includes over *0 subsidiaries, is currently a comprehensive pharmaceutical enterprise with integration of API, FDF and medical device. We are focused on ophthalmology and otorhinolaryngology products, emergency cardiovascular care products, bio-tech and customized API. In recent years, our sales revenue and profit have annually grown over *0% by means of profound strategic transformation, change of the development pattern, acceleration of independent innovation and market expansion. In ***1, we were named one of the China Pharmaceutical Industry Top **0 Enterprises. On the basis of enterprise comprehensive strength, we have been ranked in the *8th place in China Chemical Pharmaceutical Industry in ***5.

With continuous introduction of talents, we have a professional sales team (over ***0 employees) and a specialized R&D institution with many international and high-leveled experts and consultants. Well-educated and pragmatic talent reservoir prop us up in innovation and breakthrough, provide opportunities in global competition and reap the benefits of international operation.

We have been always insisting on the corporate spirit of advocating pioneering and risk-taking. With our philosophy of offering quality products, honoring code of ethics, we are working on transformation and upgrading so as to keep on enhancing the core business advantages and creating new demand. In virtue of modern management and specialized technology, we are heading towards to corporate modernization and internationalization in order to become a pharmaceutical company respected by Chinese patients and doctors.